Law360, New York (April 1, 2008, 12:00 AM EDT) -- Teva Pharmaceutical Industries Ltd. is vowing to appeal a Delaware judge's decision that blocks the Israeli generics maker from entering the U.S. market for the TAP Pharmaceutical Products Inc.'s acid reflux treatment Prevacid until May 10, 2009.
Judge Sue L. Robinson of the U.S. District Court for the District of Delaware signed off Monday on a 46-page opinion saying that Teva had failed to prove by clear and convincing evidence that two patents asserted by the plaintiffs – U.S. Patent Numbers 4,628,098 and 5,045,321 – are...
Teva To Appeal Decision Blocking Generic Prevacid
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
